SNMMI Dinner Symposium: Expanding Survival in Prostate Cancer with New Theranostics Treatment

Free SNMMI Dinner Symposium:
Expanding Survival in Prostate Cancer with New Theranostics Treatment

Date: July 28, 2022
Time: 5:30 - 8:30 pm MDT
Location: Grand America Hotel, 555 S. Main St., Salt Lake City, UT 84111
Fee: Complimentary 

SNMMI has applied for 2 hours of CE Credit for this in-person event.
Please note that seating is limited and registration will be available on a first-come, first-served basis.

Registration for this event is now closed.

SCHEDULE
5:30 pm
Registration/Networking Reception

6:00 pm
Dinner is Served

6:15-8:30 pm
Educational Program
Several new radiopharmaceuticals are now being used to stage and identify local and metastatic prostate cancer, including the recently approved Ga-68 PSMA-11 and 18F-DCFPyL. In addition, the FDA in March approved Lu 177 vipivotide tetraxetan to treat PSMA-positive metastatic castration-resistant prostate cancer. Given these new advancements in diagnosis and treatment, how does one navigate the changing landscape to provide the best outcomes for the patient?

6:15 pm
Opening Remarks
Satoshi Minoshima, MD, PhD, Anne G. Osborn Chair and Professor, Department of Radiology and Imaging Sciences, Spencer Fox Eccles School of Medicine, University of Utah; and Don Milligan, MBA, Cancer Hospital Executive Director, Huntsman Cancer Institute, University of Utah Health

6:20 pm
Metastatic Castration-Resistant Prostate Cancer and the VISION Trial
Benjamin L. Maughan MD, PharmD, Assistant Professor, Genitourinary Medical Oncology, Huntsman Cancer Institute, University of Utah

6:45 pm
Limitations of Conventional Diagnostic Imaging and Future Directions
Glen Morrell MD, PhD, Associate Professor, Department of Radiology and Imaging Sciences, Spencer Fox Eccles School of Medicine, University of Utah

7:05 pm
A Patient's Perspective
Brent Bateman

7:15 pm
Break and Dessert

7:30 pm
Principles of Radiation Therapy and New Lu-177 PSMA Treatment
Bhasker Koppula, MBBS, MD, Associate Professor and Section Chief, Nuclear Medicine, Department of Radiology and Imaging Sciences, Spencer Fox Eccles School of Medicine, University of Utah; and Richard Brown, MD, Vice Chair for Clinical Operations, Department of Radiology and Imaging Sciences, Spencer Fox Eccles School of Medicine, University of Utah

7:50 pm
Panel Discussion
Neeraj Agarwal, MD; Brent Bateman; Richard Brown, MD; Gabriel Fine, MD (Assistant Professor of Radiology and Imaging Sciences, Nuclear Medicine, University of Utah School of Medicine); Bhasker Koppula, MBBS, MD; Benjamin Maughan, MD, PharmD; and Lindsay Maxwell, APRN (Oncology & Hematology Nurse Practitioner, Huntsman Cancer Institute) 

8:20 pm
Closing Remarks
Neeraj Agarwal, MD, Professor of Medicine and Senior Director, Clinical Research Innovation, Huntsman Cancer Institute; Presidential Endowed Chair of Cancer Research; Director, Center of Investigational Therapeutics; and Director, Genitourinary Oncology Program

Please note: SNMMI is committed to ensuring that appropriate and necessary health and safety protocols will be in place for this event. We will follow all Centers for Disease Control and Prevention (CDC) safety protocols and recommendations and will comply with all federal, state, and local regulations in force at the time of the event.

CE Credit applications for physicians, pharmacists, and technologists are pending. Check back for updates regarding CE Credit status.

This event is supported by the SNMMI; Spencer Fox Eccles School of Medicine, University of Utah; Huntsman Cancer Institute, University of Utah; and a medical education grant from Telix Pharmaceuticals Inc.